Holton, J. B. et al. (1981) Galactosaemia: a new severe variant due to uridine diphosphate
galactose-4-epimerase deficiency. Arch. Dis.
Morgunov, I. and Srere, P. A. (1998) Interaction between citrate synthase and malate
dehydrogenase. Substrate channeling of oxaloacetate. J. Biol.
Graham, James W. A. et al. (2007) Glycolytic enzymes associate dynamically with
mitochondria in response to respiratory demand and support substrate channeling. Plant
Shen, L. C. and Atkinson, D. E. (1970) Regulation of pyruvate dehydrogenase from
Escherichia coli. Interactions of adenylate energy charge and other regulatory parameters.
Schrenk, D. F. and Bisswanger, H. (1984) Measurements of electron spin resonance with the
pyruvate dehydrogenase complex from Escherichia coli. Studies on the allosteric binding
site of acetyl-coenzyme A. Eur. J. Biochem. 143:561-6
Karpusas, M. et al. (1990) Proposed mechanism for the condensation reaction of citrate
synthase: 1.9-A structure of the ternary complex with oxaloacetate and carboxymethyl
coenzyme A. Biochemistry 29:2213-2219
Yagi, Takao and Matsuno-Yagi, Akemi (2003) The proton-translocating NADH-quinone
oxidoreductase in the respiratory chain: the secret unlocked. Biochemistry 42:2266-2274
Liu, X. et al. (1996) Induction of apoptotic program in cell-free extracts: requirement
for dATP and cytochrome c. Cell 86:147-157
Atlante, Anna et al. (2006) Mitochondria from the left heart ventricles of both
normotensive and spontaneously hypertensive rats oxidize externally added NADH mostly via
a novel malate/oxaloacetate shuttle as reconstructed in vitro. Int. J. Mol.
Safer, B. (1975) The Metabolic Significance of the Malate-Aspartate Cycle in Heart. Circ. Res.
Sazanov, L. A. and Jackson, J. B. (1994) Proton-translocating transhydrogenase and NAD-
and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes
to fine regulation of the tricarboxylic acid cycle activity in mitochondria. FEBS Lett.
Chou, Chi-Yuan et al. (2009) Crystal structure of biotin carboxylase in complex with
substrates and implications for its catalytic mechanism. J. Biol.
Halperin, M. L. et al. (1971) The inhibition by methylmalonic acid of malate transport by
the dicarboxylate carrier in rat liver mitochondria. A possible explanation for
hypoglycemia in methylmalonic aciduria. J. Clin.
Shieh, Jeng-Jer et al. (2003) A glucose-6-phosphate hydrolase, widely expressed outside
the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage
disease type Ia. J. Biol. Chem. 278:47098-47103
Jones, J. P. et al. (1994) Correlation between fructose 2,6-bisphosphate and lactate
production in skeletal muscle. J. Appl. Physiol. 76:2169-76
Greene, H. L. et al. (1978) ATP depletion, a possible role in the pathogenesis of
hyperuricemia in glycogen storage disease type I. J. Clin.
Burwinkel, B. et al. (1997) Autosomal glycogenosis of liver and muscle due to
phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase β
subunit (PHKB). Hum. Mol. Genet. 6:1109-1115
van Stekelenburg, G. J. and Koorevaar, G. (1972) Evidence for the existence of mammalian
acetoacetate decarboxylase: with special reference to human blood serum. Clin. Chim.
Koorevaar, G. and van Stekelenburg, G. J. (1976) Mammalian acetoacetate decarboxylase
activity. Its distribution in subfractions of human albumin and occurrence in various
tissues of the rat. Clin. Chim. Acta 71:173-183
Gasior, Maciej et al. (2007) The anticonvulsant activity of acetone, the major ketone body
in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol,
methylglyoxal, or pyruvic acid. Epilepsia
Palmer, Michael (2013) Combination treatment of epilepsy with ketogenic diet and
concurrent pharmacological inhibition of cytochrome P450 2E1. Med.
Wahren, John et al. (2012) The clinical potential of C-peptide replacement in type 1
diabetes. Diabetes 61:761-772
Vayssière, B. M. et al. (1997) Synthetic glucocorticoids that dissociate
transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol.
King, Elizabeth M. et al. (2013) Glucocorticoid repression of inflammatory gene expression
shows differential responsiveness by transactivation- and transrepression-dependent
mechanisms. PLoS One 8:e53936
Russell, Steven T. et al. (2009) Mechanism of induction of muscle protein loss by
hyperglycaemia. Exp. Cell Res. 315:16-25
Colca, Jerry R. et al. (2013) Identification of a mitochondrial target of
thiazolidinedione insulin sensitizers (mTOT) –relationship to newly identified
mitochondrial pyruvate carrier proteins. PLoS One
Zöllner, N. and Gröbner, W. (1977) Dietary feedback regulation of purine and
pyrimidine biosynthesis in man. Ciba Found. Symp. -:165-178
Löffler, W. et al. (1982) Influence of dietary purines on pool size, turnover, and
excretion of uric acid during balance conditions. Isotope studies using
15N-uric acid. Res. Exp. Med. Berl 181:113-123
Enomoto, Atsushi et al. (2002) Molecular identification of a renal urate anion exchanger
that regulates blood urate levels. Nature
Feig, Daniel I. et al. (2004) Hypothesis: Uric acid, nephron number, and the pathogenesis
of essential hypertension. Kidney Int. 66:281-287
Ramazzina, Ileana et al. (2006) Completing the uric acid degradation pathway through
phylogenetic comparison of whole genomes. Nat. Chem.
Cline, S. D. and Osheroff, N. (1999) Cytosine arabinoside lesions are position-specific
topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes.
Bartsch, Helmut and Nair, Jagadeesan (2006) Chronic inflammation and oxidative stress in
the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and
repair. Langenbecks Arch. Surg. 391:499-510
Whiteman, M. and Halliwell, B. (1996) Protection against peroxynitrite-dependent tyrosine
nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with
other biological antioxidants. Free Radic. Res. 25:275-83
Gebicki, Janusz M. et al. (2010) Reduction of protein radicals by GSH and ascorbate:
potential biological significance. Amino
Kaneko, T. et al. (1987) Lethal effects of a linoleic acid hydroperoxide and its
autoxidation products, unsaturated aliphatic aldehydes, on human diploid fibroblasts. Chem. Biol.
Gautam, Jaya et al. (2018) 4-Hydroxynonenal-induced GPR109A (HCA2 receptor)
activation elicits bipolar responses, Gαi-mediated anti-inflammatory
effects and Gβγ-mediated cell death. Br. J.
Pryor, W. A. and Stanley, J. P. (1975) A suggested mechanism for the production of
malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic
production of prostaglandin endoperoxides during autoxidation. J. Org.
Lee, Seon Hwa et al. (2005) 4-Hydroperoxy-2-nonenal-induced formation of
1,N2-etheno-2'-deoxyguanosine adducts. Chem. Res.
Landi, L. et al. (1997) DT-Diaphorase maintains the reduced state of ubiquinones in lipid
vesicles thereby promoting their antioxidant function. Free Radic.
Biol. Med. 22:329-35
Onyango, Arnold N. (2016) Endogenous Generation of Singlet Oxygen and Ozone in Human and
Animal Tissues: Mechanisms, Biological Significance, and Influence of Dietary Components.
Cell. Longev. 2016:2398573
Gourlay, Louise J. et al. (2003) Structure-function analysis of recombinant substrate
protein 22 kDa (SP-22). A mitochondrial 2-CYS peroxiredoxin organized as a decameric
Biol. Chem. 278:32631-7
Rashid, J. R. et al. (1992) Acetylation status using hydralazine in African hypertensives
at Kenyatta National Hospital. East Afr. Med. J. 69:406-408
Golka, Klaus et al. (2002) The enhanced bladder cancer susceptibility of NAT2 slow
acetylators towards aromatic amines: a review considering ethnic differences. Toxicol.
Knox, R. J. et al. (1991) Bioactivation of CB 1954: reaction of the active 4-hydroxylamino
derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.
Favaudon, V. (1982) On the mechanism of reductive activation in the mode of action of some
anticancer drugs. Biochimie 64:457-475
Welch, Ellen M. et al. (2007) PTC124 targets genetic disorders caused by nonsense
mutations. Nature 447:87-91
Goldmann, Tobias et al. (2012) A comparative evaluation of NB30, NB54 and PTC124 in
translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol.
Kerem, Eitan et al. (2008) Effectiveness of PTC124 treatment of cystic fibrosis caused by
nonsense mutations: a prospective phase II trial. Lancet
Brunetti-Pierri, Nicola (2008) Gene therapy for inborn errors of liver metabolism:
progress towards clinical applications. Ital. J.
McVie-Wylie, A. J. et al. (2008) Biochemical and pharmacological characterization of
different recombinant acid α-glucosidase preparations evaluated for the treatment of
Pompe disease. Mol. Genet. Metab. 94:448-455